Page last updated: 2024-11-11

fr 167344

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

FR 167344: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9810391
CHEMBL ID543899
CHEMBL ID1192627
SCHEMBL ID2334555
SCHEMBL ID1773342
MeSH IDM0278018

Synonyms (19)

Synonym
4-[(e)-3-[[2-[[3-[(3-bromo-2-methylimidazo[1,2-a]pyridin-8-yl)oxymethyl]-2,4-dichlorophenyl]-methylamino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n,n-dimethylbenzamide
fr167344
fr 167344
fr-167344
gtpl673
L015970
4-{(e)-2-[({[3-(3-bromo-2-methyl-imidazo[1,2-a]pyridin-8-yloxymethyl)-2,4-dichloro-phenyl]-methyl-carbamoyl}-methyl)-carbamoyl]-vinyl}-n,n-dimethyl-benzamide; hydrochloride
CHEMBL543899 ,
bdbm50067251
CHEMBL1192627
SCHEMBL2334555
SCHEMBL1773342
CS-0018453
fr167344 free base
HY-100301
215258-13-2
Q27077730
4-[(e)-3-[[2-[3-[(3-bromo-2-methylimidazo[1,2-a]pyridin-8-yl)oxymethyl]-2,4-dichloro-n-methylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n,n-dimethylbenzamide
AKOS040741767

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" FR167344 and FR173657 inhibited the B2 receptor-mediated phosphatidylinositol (PI) hydrolysis and produced a concentration-dependent rightward shift in the dose-response curve to bradykinin."( Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.
Aramori, I; Asano, M; Iwami, M; Kojo, H; Morikawa, N; Nakamura, K; Notsu, Y; O'Donnell, N; Zenkoh, J, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346473Human B2 receptor (Bradykinin receptors)1997Molecular pharmacology, Feb, Volume: 51, Issue:2
Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (58.33)18.2507
2000's5 (41.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.61 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (15.38%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]